Tyra Biosciences, Inc. (TYRA)
USD 14.52
(-4.6%)
USD 14.52
(-4.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 353 Thousand | 296 Thousand | 140 Thousand | 47 Thousand | 8000.00 |
| Gross Profit | -353 Thousand | -296 Thousand | -140 Thousand | -47 Thousand | -8000.00 |
| Operating Expenses | 79.94 Million | 58.92 Million | 26.28 Million | 9.29 Million | 3.12 Million |
| Selling, General and Administrative Expenses | 17.42 Million | 15.91 Million | 5.65 Million | 2.09 Million | 1.33 Million |
| Research and Development Expenses | 62.51 Million | 43 Million | 20.63 Million | 7.2 Million | 1.79 Million |
| Other Expenses | - | -50 Thousand | -19 Thousand | -23 Thousand | -8000.00 |
| Cost and Expenses | 79.94 Million | 58.92 Million | 26.28 Million | 9.29 Million | 3.12 Million |
| Operating Income | -79.94 Million | -58.92 Million | -26.28 Million | -9.29 Million | -3.12 Million |
| Interest Expense | - | - | - | 1000.00 | 1000.00 |
| Income Tax Expense | - | -3.6 Million | -153 Thousand | -22 Thousand | -7000.00 |
| Earnings before Tax | -69.13 Million | -55.32 Million | -26.29 Million | -9.33 Million | -4.06 Million |
| Net Income | -69.13 Million | -51.72 Million | -26.14 Million | -9.31 Million | -4.05 Million |
| Earnings Per Share Basic | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| Earnings Per Share Diluted | -1.62 | -1.23 | -0.63 | -0.22 | -0.10 |
| Weighted Average Shares Outstanding | 42.7 Million | 41.88 Million | 41.44 Million | 42.53 Million | 42.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.7 Million | 41.88 Million | 41.44 Million | 42.53 Million | 42.53 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -79.59 Million | -58.63 Million | -26.14 Million | -9.25 Million | -3.11 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 502 Thousand | - | - |
| Cost of Revenue | 126 Thousand | 122 Thousand | 353 Thousand | 102 Thousand | 82 Thousand | 86 Thousand |
| Gross Profit | -126 Thousand | -122 Thousand | -353 Thousand | 400 Thousand | -82 Thousand | -86 Thousand |
| Operating Expenses | 23.4 Million | 22.2 Million | 79.59 Million | 25.53 Million | 23.96 Million | 16.01 Million |
| Selling, General and Administrative Expenses | 5.53 Million | 5.11 Million | - | 4.95 Million | 4.69 Million | 3.85 Million |
| Research and Development Expenses | 17.87 Million | 17.08 Million | - | 20.57 Million | 19.27 Million | 12.16 Million |
| Other Expenses | - | - | - | -11 Thousand | -5000.00 | -21 Thousand |
| Cost and Expenses | 23.53 Million | 22.32 Million | 79.94 Million | 25.63 Million | 23.96 Million | 16.01 Million |
| Operating Income | -23.53 Million | -22.32 Million | -79.94 Million | -25.63 Million | -23.96 Million | -16.01 Million |
| Interest Expense | - | - | - | 2.45 Million | - | - |
| Income Tax Expense | - | 78.72 Thousand | - | 8.03 Million | -2.81 Million | -2.76 Million |
| Earnings before Tax | -18.7 Million | -18.19 Million | -69.13 Million | -22.83 Million | -21.15 Million | -13.27 Million |
| Net Income | -18.7 Million | -18.19 Million | -69.13 Million | -22.83 Million | -21.15 Million | -13.27 Million |
| Earnings Per Share Basic | -0.32 | -0.35 | - | -0.53 | -0.49 | -0.31 |
| Earnings Per Share Diluted | -0.32 | -0.35 | - | -0.53 | -0.49 | -0.31 |
| Weighted Average Shares Outstanding | 58.66 Million | 52.22 Million | 42.7 Million | 42.96 Million | 42.86 Million | 42.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.66 Million | 52.22 Million | 42.7 Million | 42.96 Million | 42.86 Million | 42.58 Million |
| Gross Margin | - | - | - | 0.80 | - | - |
| EBIT Margin | - | - | - | -50.86 | - | - |
| Profit Margin | - | - | - | -45.48 | - | - |
| EBITDA | -23.4 Million | -22.2 Million | - | -25.53 Million | -23.88 Million | -15.92 Million |
| Earnings Before Tax Margin | - | - | - | -51.06 | - | - |
300628
SIGY
IVZ
PLFF
000428
600095